Norman Fields Gottscho Capital Management’s Kindred Biosciences, Inc. KIN Stock Holding History

Norman Fields Gottscho Capital Management’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-13,900	Closed	-$69K	–	82
2016 Q3	$69K	Hold	13,900	–	–	0.05%	72
2016 Q2	$49K	Hold	13,900	–	–	0.03%	68
2016 Q1	$48K	Hold	13,900	–	–	0.03%	68
2015 Q4	$47K	Sell	13,900 -2,850	-17%	-$13.2K	0.03%	66
2015 Q3	$87K	Hold	16,750	–	–	0.06%	69
2015 Q2	$114K	Hold	16,750	–	–	0.07%	71
2015 Q1	$120K	Hold	16,750	–	–	0.08%	67
2014 Q4	$125K	Buy	+16,750	New	+$142K	0.08%	65

Other funds holding KIN

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Norman Fields Gottscho Capital Management's KIN Position: Q4 2016 in Review

Norman Fields Gottscho Capital Management sold out of Kindred Biosciences, Inc. (KIN) in Q4 2016, closing a stake of 13,900 shares — an estimated $69K sold.

Norman Fields Gottscho Capital Management first reported a position in KIN in Q4 2014 and held it in 8 quarters. The position peaked at $125K in Q4 2014. 43 funds tracked by Wall St. Rank hold KIN as of Q4 2016.

Norman Fields Gottscho Capital Management reported no remaining Kindred Biosciences, Inc. position as of Q4 2016 after selling out during the quarter.
Norman Fields Gottscho Capital Management sold 13,900 Kindred Biosciences, Inc. shares in Q4 2016, an estimated $69K.
Norman Fields Gottscho Capital Management first reported a position in Kindred Biosciences, Inc. in Q4 2014 and held it in 8 quarters.
Norman Fields Gottscho Capital Management's Kindred Biosciences, Inc. position peaked at $125K in Q4 2014.
43 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2016.

Based on Norman Fields Gottscho Capital Management's 13F filing for Q4 2016, filed 4 Jan 2017.